Navigation Links
Health Experts Call for New Strategies to Combat Alarming Rise in Diabetes
Date:9/25/2008

PARIS, September 25 /PRNewswire/ --

- Johnson & Johnson Diabetes Institute Launched as New Research Suggests Improved Patient Education May Play Key Role in Halting Escalating Disease in the EMEA Region

Experts have predicted that by 2025, the number of people with diabetes will have increased by 20 per cent within Europe, 80 percent within Eastern Mediterranean and Middle Eastern populations and 80 percent within the African patient population(1). Diabetes specialists and patients agree that improved education for healthcare professionals and patients could, however, reduce both the financial and personal impact of diabetes on our society.

New research unveiled today at the opening of the Johnson & Johnson Diabetes Institute in Paris, a new state-of-the art diabetes training facility for healthcare professionals involved in diabetes care across Europe, the Middle East and Africa (EMEA), reinforced this belief and showed overwhelming support for improved education measures as a key enabler for patients to better manage the condition.

"With global health expenditure for diabetes and its complications set to exceed US$302.5 billion by 2025, a 30 per cent increase, and some of the largest segments of that expected in Europe, the Middle East and Africa, we interviewed patients and healthcare professionals in six countries representative of this vast region, to see what practical solutions were needed", said former Acting U.S. Surgeon General, Kenneth Moritsugu M.D., M.P.H., FACPM, who serves as the Global Johnson & Johnson Diabetes Institutes' Chairman.

"92% of healthcare professionals surveyed believe patient education can help reduce the burden of diabetes on society, yet despite this, 58% of those patients surveyed want more information and advice from their healthcare professional on how to better manage the disease. This discrepancy can be explained by the fact that healthcare professionals themselves are seeking new and im
'/>"/>

SOURCE Johnson & Johnson Diabetes Institute
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Connecticut State Medical Society and Genomas Co-Sponsor Forum on DNA-Guided Medicine and the Path to Personalized Health Care
2. Helix BioPharma to Present L-DOS47 Research Findings at the National Research Council of Canadas Eighth Annual General Meeting of the Genomics and Health Initiative in Saskatoon, Canada
3. Fujitsu PalmSecure and HT Systems PatientSecure Selected by BayCare Health System to Protect Patient Confidentiality and Prevent Medical Identity Theft
4. Robert L. Brent, MD, PhD, Honored with 2008 Alfred I. duPont Award for Excellence in Childrens Health Care
5. Global Psychiatrists Unite to Improve Services in Mental Health
6. Cardinal Health Invites Health Care Providers to Apply for $1 Million in Grants to Fund Patient Safety Initiatives
7. Ardea Biosciences to Present at the UBS Global Life Sciences Conference and the Third Annual JMP Securities Healthcare Focus Conference
8. Hoana Medical and Hawaii Union Health and Welfare Trust Funds Partner to Fix Healthcare
9. A Better Tomorrow Treatment Center Inc., Forterus Inc.s Behavioral Healthcare Subsidiary, is the First in the Nation to Offer DNA-Customized Treatment for Individuals with a Genetic Predisposition for Addictive Behavior
10. The Wall Street Transcript Interviews AMDL, Inc. CEO & President Gary Dreher for Fall Healthcare Issue
11. Valley Baptist Health System Selects Concuitys ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , SANTA CRUZ, Calif., Nov. 24 /PRNewswire/ ...io Career Center, the nation,s leading online job ...als. ,, Northwestern and Columbia University ar...ajor life science training Institutions. ,, The... post-graduates in the life sciences. While there ...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November.... (Nasdaq: DCGN ) today announced that it has rece...ing in the company,s common stock will be,suspende...e filed with the,Securities and Exchange Commissio...sting on Nasdaq, unless the company files an appea...
(Date:11/24/2009)... Health care employment grew b...e only one to show consistent growth during the U....tals remain in trouble, and health systems are com...nnel, instead of just administrators. , ... care employment continued growing in October desp...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia/ --...& Trademark Office (PTO) has allowed the paten...or NOD technology. , NOD technology is a ...or,proteins into bio-adhesive nano-particles to en... as injections. NOD technology is a platform techn...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
... 26 Joseph F. Finn, Jr., C.P.A. ("Finn"), announc...erest from pharma companies in the intellectual pr.... , , In preclinical studies, GCS-100 inhibited b...s. Development and growth of solid tumors require...iver oxygen and nutrients to a tumor. Galectin-3 ...
...outstanding, world-changing leaders to participate...s of the TED Conference introduced today the 25 ne... international conference, TEDGlobal. These Fellow...ttending TEDGlobal 2009, to be held in Oxford, UK,...TED Fellows selected for the TED2009 Conference, h...
...ornia and AMSTERDAM, May 26 ,Agendia, a world lead...d the,opening of its U.S. clinical genomics labora...lly-licensed and compliant with the Clinical Labor...ed by the Centers for Medicare,and Medicaid Servic...ncer genomics laboratory, Agendia has,over the pas...
Other Biology Technology:Prospect Therapeutics, Inc.'s GCS-100 Inhibited Blood Vessel Formation in a Variety of Cancer Models 2TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford 2TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford 3TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford 4TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford 5Agendia Opens CLIA-Registered U.S. Genomics Laboratory 2Agendia Opens CLIA-Registered U.S. Genomics Laboratory 3
(Date:11/25/2009)...Head of the Cell Death Research Laboratory in the ...een awarded the prestigious Johnson & Johnson Focu...ause of brain cell damage in Parkinson,s disease. ...s in support of innovation and excellence in scien...d earlier this month at an event at the Hyatt Rege...
(Date:11/24/2009)...s it has been prescribed by traditional healers in...s and stomach pain to fever and flu. , Now for th...have been able to scientifically prove the pain re...known as Brazilian mint. , Testing this ancient S...cher Graciela Rocha was able to show that when pre...
(Date:11/24/2009)...on of a remarkable class of ring-shaped protein mo...wrence Berkeley National Laboratory (Berkeley Lab)...beamline at the Advanced Light Source (ALS). These...ion and replication, and are vital to the survival...ents, such as the human papillomavirus, which has ...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 1Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 2Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 3Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 4Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 5Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 6Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 7Cancer Diagnostics Company On Q ity Raises 2421M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy 5961 1Cancer Diagnostics Company On Q ity Raises 2421M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy 5961 2Varian Inc to Release Fourth Quarter and Full Fiscal Year 2009 Financial Results 5957 1
...searchers at NYU Langone Medical Center may have d...ndrome (BTHS). BTHS, a sometimes fatal disease, is...y in males that leads to infection or heart failur...alcium-independent phospholipase A2 in the pathoge...n the Proceedings of the National Academy of Scie...
...N ARBOR, Mich. Researchers from the University of...ied a gene that is overexpressed in 90 percent of .... , Expression of the gene, Ataxia Telangiectasia...erage 20 times higher in pancreatic cancer cells t...the gene appears to make pancreatic cancer cells r...
... international team of scientists, led by Monash U...of a superbug that kills elderly hospital patients... save lives and health care systems billions of do...n the prestigious scientific journal Nature , unr...Clostridium difficile and solved the mystery surr...
Other Biology News:New potential therapeutic target discovered for genetic disorder -- Barth syndrome 2U-M researchers ID gene involved in pancreatic cancer 2Monash scientists debug superbug 2
Mouse Anti-Human Killer Cell Immunoglobulin-like Receptor, Two Domains, Long Cytoplasmic Tail, 2 (KIR2DL2 (KIR2DL3) Monoclonal Antibody, Unconjugated from Lifespan Biosciences
2,7-Dichlorofluorescein (Fluorescence Reference Standard) from AnaSpec
Mouse Anti-Human Relaxin-2, pro- Monoclonal Antibody, Unconjugated, Clone fred from Immundiagnostik
Mouse Anti-Human Kallikrein 2 Monoclonal Antibody, Unconjugated, Clone 6B7 from ImmuQuest Ltd.
Biology Products: